Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

10 Jun 2025 17:57

RNS Number : 2836M
Savills PLC
10 June 2025
 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

 

Vesting of Deferred Share Awards

 

Awards over ordinary shares of the Company under the Company's Deferred Share Plans have become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustees of the Group's Employee Benefit Trust have effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares, to Directors and PDMRs of the Company as follows:

 

Director/ PDMR

Number of Shares Transferred

Number of Shares Disposed

Shareholding following this notification

Shareholding as a % of issued share capital

Mark Ridley (Director)

5,211

94,689

237,065

0.16%

Simon Shaw (Director)

39,500

35,196

222,079

0.15%

Martin Fidden (PDMR)

7,598

-

25,382

0.02%

Alex Jeffrey (PDMR)

120,491

-

238,931

0.17%

Chris Lee (PDMR)

2,166

39,373

121,166

0.08%

Raymond Lee (PDMR)

71,181

-

176,181

0.12%

David Lipson (PDMR)

3,770

3,760

128,886

0.09%

James Sparrow (PDMR)

21,431

19,096

114,450

0.08%

 

The share price on disposal of all shares was £9.625 per share.

 

 

Grant of Deferred Share Awards

 

The Company announces that on 10 June 2025 the grant of the share-based element of 2024 profit share awards has been made under The Savills Deferred Share Bonus Plan to Directors and PDMRs as follows:

 

Director/ PDMR

Number of shares subject to The Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 10 June 2025

Mark Ridley (Director)

105,394

Simon Shaw (Director)

81,120

Alex Jeffrey (PDMR)

57,053

Chris Lee (PDMR)

16,597

James Sparrow (PDMR)

41,493

These awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

 

 

The Company announces that on 10 June 2025 the grant of an award has been made under The Savills Deferred Share Plan (No.2 Plan) to the following PDMR:

PDMR

Number of shares subject to The Savills Deferred Share Plan (No.2 Plan) awarded to the PDMR on 10 June 2025

Martin Fidden (PDMR)

15,560

This award has a Deferred Period of three years and is subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

 

The Company announces that on 10 June 2025 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan (No.2 Plan) to a PDMR based in the United States of America as follows:

 

PDMR

Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 10 June 2025

David Lipson (PDMR)

68,999

One-third of Mr Lipson's award will vest on each of the three anniversaries subsequent to the date of grant subject to continued employment. The award is subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.

 

Resulting beneficial interests under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan) further to the above notifications are as follows:

Director/ PDMR

Resulting beneficial interest under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan)

Mark Ridley (Director)

267,995

Simon Shaw (Director)

210,101

Martin Fidden (PDMR)

30,635

Alex Jeffrey (PDMR)

183,558

Chris Lee (PDMR)

42,999

Raymond Lee (PDMR)

52,136

David Lipson (PDMR)

181,915

James Sparrow (PDMR)

148,611

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the Director/ PDMR

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Martin Fidden

4. Alex Jeffrey

5. Chris Lee

6. Raymond Lee

7. David Lipson

8. James Sparrow

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Chief Executive Officer - Asia Pacific (ex-Greater China)/ PDMR

4. Chief Executive Officer - Savills Investment Management/ PDMR

5. Group Legal Director and Company Secretary/ PDMR

6. Chief Executive - Hong Kong, Macau and Greater China/ PDMR

7. Chief Executive Officer - Savills North America/ PDMR

8. Chief Executive Officer, UK & EMEA/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

1) Vesting of awards under the Company's Deferred Share Plans and sale of shares

2) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Plans

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

1)

Acquisition

£nil per share

 

 

 

 

 

 

Disposal

£9.625 per share

1. 99,900

2. 74,696

3. 7,598

4. 120,491

5. 41,539

6. 71,181

7. 7,530

8. 40,527

 

1. 94,689

2. 35,196

3. n/a

4. n/a

5. 39,373

6. n/a

7. 3,760

8. 19,096

 

2)

£nil per share

1. 105,394

2. 81,120

3. 15,560

4. 57,053

5. 16,597

6. n/a

7. 68,999

8. 41,493

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

Vesting of awards and sale of associated shares - 9 June 2025

Grant of awards - 10 June 2025

(g)

Place of the transaction

 

Vesting of awards - Outside a trading venue

Sale of associated shares - London Stock Exchange

Grant of awards - Outside a trading venue

 

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

10 June 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGMVVGVGKZM
Date   Source Headline
9th Oct 20179:27 amRNSHolding(s) in Company
3rd Oct 201712:00 pmRNSIssue of Equity
12th Sep 20174:38 pmRNSDirector/PDMR Shareholding
1st Sep 20177:00 amRNSTotal Voting Rights
24th Aug 20179:53 amRNSHolding(s) in Company
15th Aug 20174:28 pmRNSBlock listing Interim Review
15th Aug 20179:18 amRNSDirector/PDMR Shareholding
15th Aug 20178:58 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSHalf-year Report
28th Jul 201712:20 pmRNSAcquisition
18th Jul 201712:00 pmRNSIssue of Equity
11th Jul 20175:00 pmRNSDirector/PDMR Shareholding
30th Jun 20177:00 amRNSHolding(s) in Company
13th Jun 20173:12 pmRNSDirector/PDMR Shareholding
12th Jun 20175:55 pmRNSHolding(s) in Company
5th Jun 20172:57 pmRNSHolding(s) in Company
5th Jun 201710:24 amRNSHolding(s) in Company
1st Jun 20173:21 pmRNSDirector/PDMR Shareholding
24th May 201711:00 amRNSIssue of Equity
22nd May 201712:25 pmRNSDirector/PDMR Shareholding
18th May 201711:20 amRNSDirector/PDMR Shareholding
17th May 20175:00 pmRNSDirector/PDMR Shareholding
15th May 20174:14 pmRNSDirector/PDMR Shareholding
11th May 20172:07 pmRNSDirector/PDMR Shareholding
9th May 20174:31 pmRNSAGM Special Business
9th May 20174:30 pmRNSResult of AGM
9th May 201710:30 amRNSAGM Statement
2nd May 20177:00 amRNSTotal Voting Rights
24th Apr 201712:36 pmRNSDirector/PDMR Shareholding
18th Apr 20172:48 pmRNSDirector/PDMR Shareholding
11th Apr 20174:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:50 pmRNSAnnual Report and AGM Notice
3rd Apr 201712:00 pmRNSIssue of Equity
3rd Apr 20177:00 amRNSTotal Voting Rights
24th Mar 20179:30 amRNSDirector/PDMR Shareholding
22nd Mar 20177:00 amRNSFinal Results
13th Mar 20172:50 pmRNSDirector/PDMR Shareholding
15th Feb 20175:00 pmRNSBlock listing Interim Review
13th Feb 201712:35 pmRNSDirector/PDMR Shareholding
13th Jan 201712:14 pmRNSHolding(s) in Company
12th Jan 201711:35 amRNSDirector/PDMR Shareholding
12th Jan 20177:00 amRNSPre-Close Trading Update
3rd Jan 201712:19 pmRNSHolding(s) in Company
13th Dec 20164:22 pmRNSDirector/PDMR Shareholding
25th Nov 201610:06 amRNSHolding(s) in Company
14th Nov 201611:21 amRNSDirector/PDMR Shareholding
2nd Nov 20162:58 pmRNSHolding(s) in Company
26th Oct 20163:56 pmRNSHolding(s) in Company
11th Oct 20162:26 pmRNSDirector/PDMR Shareholding
3rd Oct 201610:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.